Galapagos « Terug naar discussie overzicht

Galapagos 200 euro per aandeel

957 Posts, Pagina: « 1 2 3 4 5 6 ... 10 11 12 13 14 15 16 17 18 19 20 ... 44 45 46 47 48 » | Laatste
[verwijderd]
2
Introductie Filgotinib door Gilead nabij !!!!,

We have the following exciting opportunity in our Foster City, CA location:Associate Director Opinion Leader Programs (OLP), Rheumatoid Arthritis (RA) MarketingThis role is a foundational role and the beginning of a core build of the US marketing team for the launch of FILGOTINIB in Rheumatoid Arthritis. As one of the first members of the US commercial team, this individual will assume a key leadership role responsible for a multitude of OLP-related activities in preparing the US commercial organization and the external marketplace for this important launch into a novel therapeutic area for Gilead.

jobs.adweek.com/job/associate-directo...
Bruyne
0
Kost niets om iemand aan te nemen in geval van. Alleszins de markt reageert hier niet op. Wil hiermee niets afbreken, zit ook long...
[verwijderd]
0
quote:

inspirator schreef op 2 april 2018 21:13:

Introductie Filgotinib door Gilead nabij !!!!,

We have the following exciting opportunity in our Foster City, CA location:Associate Director Opinion Leader Programs (OLP), Rheumatoid Arthritis (RA) MarketingThis role is a foundational role and the beginning of a core build of the US marketing team for the launch of FILGOTINIB in Rheumatoid Arthritis. As one of the first members of the US commercial team, this individual will assume a key leadership role responsible for a multitude of OLP-related activities in preparing the US commercial organization and the external marketplace for this important launch into a novel therapeutic area for Gilead.

jobs.adweek.com/job/associate-directo...

Ook Gilead laat activteit zien rondom Filgotinib.
Als je deze vacature leest van Gilead aangaande marktintroduktie van Filgotinib, dan wordt Filgotinib een megabuster.

aston.martin
4
quote:

inspirator schreef op 2 april 2018 16:48:

[...]

In ieder geval komt er nieuws van Galapagos

Open deze link

www.biopharmcatalyst.com/calendars/fd...

Zoek naar glpg

En zie daar 4 april aankondigingen,

Verdorie, je hebt gelijk: 4 april,aankondigingen!!!

Een klein detail echter: de aankondigingen waren 4 april 2017.

Nu dacht ik dat we ondertussen al wel in 2018 zijn...
Lange winterslaap gedaan zeker?

En dat de studies eind Q2 pas afgelopen zijn heb je niet gelezen waarschijnlijk.

Die 4 april is gewoon de dag dat Galapagos vorig jaar de start van de studies heeft aangekondigd.

Man, man, man... en jij hebt het lef om Onno een CEO onwaardig te noemen.

Beschamend gewoon

[verwijderd]
0
Beschamend is dat Onno vd Stolpe grote verhalen ophangt en dat hij aandeelhouders op korte ternijn beloofd, dit in de publiciteit te brengen. En vervolgens blijft het stil.

Q2 komt er in ieder geval nieuws.

[verwijderd]
1
quote:

inspirator schreef op 2 april 2018 21:13:

Introductie Filgotinib door Gilead nabij !!!!,

We have the following exciting opportunity in our Foster City, CA location:Associate Director Opinion Leader Programs (OLP), Rheumatoid Arthritis (RA) MarketingThis role is a foundational role and the beginning of a core build of the US marketing team for the launch of FILGOTINIB in Rheumatoid Arthritis. As one of the first members of the US commercial team, this individual will assume a key leadership role responsible for a multitude of OLP-related activities in preparing the US commercial organization and the external marketplace for this important launch into a novel therapeutic area for Gilead.

jobs.adweek.com/job/associate-directo...

Wauw
nelis h
0
quote:

moneymaker_BX schreef op 2 april 2018 23:11:

Wat heeft dit van doen met Galapagos?
Filgotinib en RA hebben inderdaad niets met galapagos van doen ...
[verwijderd]
0
quote:

inspirator schreef op 2 april 2018 21:13:

Introductie Filgotinib door Gilead nabij !!!!,

We have the following exciting opportunity in our Foster City, CA location:Associate Director Opinion Leader Programs (OLP), Rheumatoid Arthritis (RA) MarketingThis role is a foundational role and the beginning of a core build of the US marketing team for the launch of FILGOTINIB in Rheumatoid Arthritis. As one of the first members of the US commercial team, this individual will assume a key leadership role responsible for a multitude of OLP-related activities in preparing the US commercial organization and the external marketplace for this important launch into a novel therapeutic area for Gilead.

jobs.adweek.com/job/associate-directo...

launch of FILGOTINIB in Rheumatoid Arthritis
[verwijderd]
0
quote:

inspirator schreef op 2 april 2018 22:53:

Beschamend is dat Onno vd Stolpe grote verhalen ophangt en dat hij aandeelhouders op korte ternijn beloofd, dit in de publiciteit te brengen. En vervolgens blijft het stil.

Q2 komt er in ieder geval nieuws.

Nou Onno heeft de prijs gewonnen:

Meest waardeloze CEO van q1 2018

Gelukkig komt er morgen nieuws

[verwijderd]
0
Er maar roepen blijf bij ons.
Had toch mooi 20% extra rendement opgeleverd als aandeel Galapagos volgende week 100 euro staat.
[verwijderd]
0
Gilead gaat vaart zetten achter introduktie Filgotinib.

Implement and evolve current filgotinib global market development strategic plan and communication platform.

www.glassdoor.nl/job-listing/director...,41_KE42,57.htm?jl=2552748938&countryRedirect=true

ps mooie functie voor Onno vd Stolpe: kan hij zich weer eens uitleven op zijn job.

In ieder geval bevestiging dat Filgotinib een succesvol produkt is; nu nog de marktintroduktie.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

Job Description

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Asia, Europe and Australia.

We have the following exciting opportunity in our Foster City, CA location:

Specific Responsibilities

Reporting to the Senior Director (Inflammations & Respiratory), Commercial Planning (CP), this role will oversee market preparation in RA/IBD and future indications for filgotinib (e.g., Ankylosing Spondilitis, Psoriatic Arthritis, Uveitis, etc). The candidate will be accountable for collaborative commercialization plan and strategy development in coordination with regional teams.

Essential Duties and Job Functions
Implement and evolve current filgotinib global market development strategic plan and communication platform.
Partner with Sr Director and key stakeholders including regional teams, R&D, biomarkers team, medical affairs, and business development to develop a market development plan
Develop and evolve tactical market development plan and communication plan in collaboration with clinical and medical affairs, including conference presence
Collaborate closely with other members of cross functional team (market research, payer & market access, competitive intelligence, and Senior Director)
Design and implement a process to ensure adoption of global market development deliverables by regional and country operations.
Work closely with SD to develop and execute efficient global governance for inflammation
Lead the strategic planning process in 2018 ensuring collaboration with cross functional teams.
Lead by example, respecting Gilead core values of integrity, teamwork, accountability, excellence, diversity and inclusion.
Knowledge, Experience and Skills
The ideal candidate will be a proven business leader with a passion for commercializing breakthrough medicine, a global mindset, strong scientific acumen, strategic thinking.
A successful candidate will have understanding and experience in pre-launch market development work in disease areas
Demonstrated ability to develop successful partnership including the following functions – R&D, Medical affairs, Pricing & access, Health economics/Outcomes Research, Policy, government affairs, public affairs.
Position requires proven “leading and influencing without authority” skills.
Successful candidate needs to have a deep understanding of the evolving payer and market landscapes, health reforms, and can anticipate and prioritize what is needed in these rapidly evolving landscapes with extremely challenging healthcare economics.
Prior experience in developing a market in early disease life cycle is preferred.
Bachelor’s degree is required (advanced degree in life sciences or M.B.A. preferred)
10+ years’ experience in the biopharmaceutical industry. Experiences to include global product strategic planning, in-country marketing, new product planning, portfolio management and lifecycle management
whoiam
0
[verwijderd]
0
quote:

inspirator schreef op 4 april 2018 07:34:

Gilead gaat vaart zetten achter introduktie Filgotinib.

Implement and evolve current filgotinib global market development strategic plan and communication platform.

www.glassdoor.nl/job-listing/director...,41_KE42,57.htm?jl=2552748938&countryRedirect=true

ps mooie functie voor Onno vd Stolpe: kan hij zich weer eens uitleven op zijn job.

In ieder geval bevestiging dat Filgotinib een succesvol produkt is; nu nog de marktintroduktie.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

Job Description

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Asia, Europe and Australia.

We have the following exciting opportunity in our Foster City, CA location:

Specific Responsibilities

Reporting to the Senior Director (Inflammations & Respiratory), Commercial Planning (CP), this role will oversee market preparation in RA/IBD and future indications for filgotinib (e.g., Ankylosing Spondilitis, Psoriatic Arthritis, Uveitis, etc). The candidate will be accountable for collaborative commercialization plan and strategy development in coordination with regional teams.

Essential Duties and Job Functions
Implement and evolve current filgotinib global market development strategic plan and communication platform.
Partner with Sr Director and key stakeholders including regional teams, R&D, biomarkers team, medical affairs, and business development to develop a market development plan
Develop and evolve tactical market development plan and communication plan in collaboration with clinical and medical affairs, including conference presence
Collaborate closely with other members of cross functional team (market research, payer & market access, competitive intelligence, and Senior Director)
Design and implement a process to ensure adoption of global market development deliverables by regional and country operations.
Work closely with SD to develop and execute efficient global governance for inflammation
Lead the strategic planning process in 2018 ensuring collaboration with cross functional teams.
Lead by example, respecting Gilead core values of integrity, teamwork, accountability, excellence, diversity and inclusion.
Knowledge, Experience and Skills
The ideal candidate will be a proven business leader with a passion for commercializing breakthrough medicine, a global mindset, strong scientific acumen, strategic thinking.
A successful candidate will have understanding and experience in pre-launch market development work in disease areas
Demonstrated ability to develop successful partnership including the following functions – R&D, Medical affairs, Pricing & access, Health economics/Outcomes Research, Policy, government affairs, public affairs.
Position requires proven “leading and influencing without authority” skills.
Successful candidate needs to have a deep understanding of the evolving payer and market landscapes, health reforms, and can anticipate and prioritize what is needed in these rapidly evolving landscapes with extremely challenging healthcare economics.
Prior experience in developing a market in early disease life cycle is preferred.
Bachelor’s degree is required (advanced degree in life sciences or M.B.A. preferred)
10+ years’ experience in the biopharmaceutical industry. Experiences to include global product strategic planning, in-country marketing, new product planning, portfolio management and lifecycle management
Prima
[verwijderd]
0
Beurskingpin
0
quote:

whoiam schreef op 4 april 2018 07:50:

Waarom altijd gilead, uiteindelijk is toch Galapagos die dat product heeft?
Uhm, excuseer?
[verwijderd]
1
quote:

inspirator schreef op 4 april 2018 07:34:

Gilead gaat vaart zetten achter introduktie Filgotinib.

Implement and evolve current filgotinib global market development strategic plan and communication platform.

www.glassdoor.nl/job-listing/director...,41_KE42,57.htm?jl=2552748938&countryRedirect=true

ps mooie functie voor Onno vd Stolpe: kan hij zich weer eens uitleven op zijn job.

In ieder geval bevestiging dat Filgotinib een succesvol produkt is; nu nog de marktintroduktie.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.

Job Description

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Asia, Europe and Australia.

We have the following exciting opportunity in our Foster City, CA location:

Specific Responsibilities

Reporting to the Senior Director (Inflammations & Respiratory), Commercial Planning (CP), this role will oversee market preparation in RA/IBD and future indications for filgotinib (e.g., Ankylosing Spondilitis, Psoriatic Arthritis, Uveitis, etc). The candidate will be accountable for collaborative commercialization plan and strategy development in coordination with regional teams.

Essential Duties and Job Functions
Implement and evolve current filgotinib global market development strategic plan and communication platform.
Partner with Sr Director and key stakeholders including regional teams, R&D, biomarkers team, medical affairs, and business development to develop a market development plan
Develop and evolve tactical market development plan and communication plan in collaboration with clinical and medical affairs, including conference presence
Collaborate closely with other members of cross functional team (market research, payer & market access, competitive intelligence, and Senior Director)
Design and implement a process to ensure adoption of global market development deliverables by regional and country operations.
Work closely with SD to develop and execute efficient global governance for inflammation
Lead the strategic planning process in 2018 ensuring collaboration with cross functional teams.
Lead by example, respecting Gilead core values of integrity, teamwork, accountability, excellence, diversity and inclusion.
Knowledge, Experience and Skills
The ideal candidate will be a proven business leader with a passion for commercializing breakthrough medicine, a global mindset, strong scientific acumen, strategic thinking.
A successful candidate will have understanding and experience in pre-launch market development work in disease areas
Demonstrated ability to develop successful partnership including the following functions – R&D, Medical affairs, Pricing & access, Health economics/Outcomes Research, Policy, government affairs, public affairs.
Position requires proven “leading and influencing without authority” skills.
Successful candidate needs to have a deep understanding of the evolving payer and market landscapes, health reforms, and can anticipate and prioritize what is needed in these rapidly evolving landscapes with extremely challenging healthcare economics.
Prior experience in developing a market in early disease life cycle is preferred.
Bachelor’s degree is required (advanced degree in life sciences or M.B.A. preferred)
10+ years’ experience in the biopharmaceutical industry. Experiences to include global product strategic planning, in-country marketing, new product planning, portfolio management and lifecycle management
Nou Onno,
We komen vanaf vandaag iedere dagbij je eten.
Kun tenminste nog iets klaarmaken voor je aandeelhouders.

Tot vanavond.
Lust trouwens alles en een goede wijn zouden we op prijs stellen.
[verwijderd]
0
Media

Nico PR Bakker
?

@TheDailyTurbo
3 min3 minuten geleden
Meer Nico PR Bakker heeft geretweet Marjan Huisman
#GALAPAGOS vervolgt zijn daily downtrend en valt onder de weekly SMA richting de onderkant van het stijgingskanaal rond 75,00...met deze voortgang wordt de TT Long Setup ingetrokken.....Nico PR Bakker heeft toegevoegd,
[verwijderd]
0
Galapagos is 200 euro waard in toekomst

Onno vd Stolpe is nog geen dubbeltje waard.
957 Posts, Pagina: « 1 2 3 4 5 6 ... 10 11 12 13 14 15 16 17 18 19 20 ... 44 45 46 47 48 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 10 mei 2024 09:08
Koers 26,740
Verschil -0,080 (-0,30%)
Hoog 26,800
Laag 26,720
Volume 543
Volume gemiddeld 85.254
Volume gisteren 45.851

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront